Survival and Prognostic Factors of Primary Retroperitoneal Sarcomas After Surgery: a Single-center Experience

NCT06396962 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2024-05-02

No results posted yet for this study

Summary

he percentage of retroperitoneal sarcomas (RPS) among all soft tissue sarcomas ranges from 10%-15%. Surgery remains the gold standard for RPS. In this study, we analyzed the impact of surgical treatment for primary RPS on recurrence and overall mortality at a Chinese institution and identified and evaluated prognostic variables.

Conditions

  • Primary Retroperitoneal Sarcoma

Interventions

OTHER

WANG DAORONG

surgery

Sponsors & Collaborators

  • Northern Jiangsu People's Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-29
Primary Completion
2024-04-29
Completion
2024-04-29

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06396962 on ClinicalTrials.gov